Evidence map›Paper›PMID 33486387›Full record

ArticleDiagnostic microbiology and infectious disease2021

An Australian diagnostic microbiology surge response to the COVID-19 pandemic.

Rebecca Sparks, Rifky Balgahom, Catherine Janto, Adam Polkinghorne, James Branley, Harsha Samarasekara

Abstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebecca SparksDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia.
Rifky BalgahomDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia.
Catherine JantoDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia.
Adam PolkinghorneDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia; Nepean Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood, New South Wales, Australia.
James BranleyDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia; Nepean Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood, New South Wales, Australia.
Harsha SamarasekaraDepartment of Microbiology and Infectious Diseases, NSW Health Pathology Nepean, Penrith, New South Wales, Australia. Electronic address: harsha.samarasekara@health.nsw.gov.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnostic microbiology services form a critical component of the response to infectious disease outbreaks. Like previous respiratory virus pandemics, the COVID-19 pandemic has placed significant strains on the standing capacity of laboratories around the world. In this case study, we describe the surge response required by our laboratory to meet the fluctuating demand for SARS-CoV-2 in our regional pathology service in Western Sydney, Australia between March and May 2020. While the overall number of SARS-CoV-2 PCR positive cases was relatively low compared to other Australian local health districts, testing numbers were highly unpredictable and changed on a weekly basis as local outbreaks were detected. As with other laboratories, numerous other challenges were also faced during this period, including the requirement to introduce a new and unaccredited diagnostic PCR assay for SARS-CoV-2, local and global shortages of reagents for sampling and sample processing, and a significant institutional SARS-CoV-2 outbreak in our laboratory catchment area. A successful service delivery during this period could only be maintained by a dynamic whole-of-laboratory and organizational response including (1) operational changes to the hours of service and the expansion of diagnostic testing at our laboratory site and other sites within our organization (2) careful management of specialist staff and re-training and recruitment of additional staff (3) changes to laboratory workflows to improve SARS-CoV-2 PCR test turnaround time and to accommodate limits to precious laboratory reagents; (4) clear communication within our laboratory and the NSW Health Pathology organization; and (5) collaborative co-ordination and support by NSW Health Pathology.

Indexed as

COVID-19COVID-19 TestingMicrobiologyAustraliaClinical Laboratory ServicesHumansLaboratoriesMedical Laboratory PersonnelPolymerase Chain ReactionTime FactorsCOVID-19Laboratory managementSARS-CoV-2Service deliveryTurnaround time

Identifiers

PMID33486387
PMCPMC7833915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.